Akari Therapeutics PLC (AKTX)
0.97
-0.03
(-2.99%)
USD |
NASDAQ |
Dec 20, 16:00
0.95
-0.02
(-2.06%)
After-Hours: 20:00
Akari Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Ascendis Pharma AS | -8.104 |
| Cellectis SA | 0.3579 |
| Adaptimmune Therapeutics PLC | 0.6234 |
| Biodexa Pharmaceuticals PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.734M |
| Total Liabilities (Quarterly) | 9.428M |
| Shareholders Equity (Quarterly) | -6.694M |